Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG)

CAPS Rating: 2 out of 5

The Company is seeking to develop and commercialize new diagnostic and therapeutic products based on a recently discovered group of genes known as microRNAs.

Recs

0
Player Avatar pchop123 (76.56) Submitted: 7/25/2012 10:00:07 AM : Underperform Start Price: $9.81 ROSG Score: +29.00

Run away fast

Featured Broker Partners


Advertisement